Home > Analytics > AARTI DRUGS

AARTI DRUGS
Intrinsic Value | Fundamental Analysis

BOM : 524348     NSE : AARTIDRUGS    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Average
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Sep 25,2023
Price(EOD): ₹ 552.50
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 5,077.48 Cr
Value of ₹ 1 Lac invested in AARTI DRUGS
on Sep 25,2018 (price: ₹ 142.66)

₹ 1 L

₹ 3.87 L

1W : -6.8% 1M : -1.4% 1Y : 20%
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results
AARTI DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Industry Peers & Returns1W1M1Y
AARTI DRUGS -6.8% -1.4% 20%
SUN PHARMACEUTICAL INDUSTRIES -2.1% 0.6% 23.6%
DIVIS LABORATORIES -1.4% 2% 2%
CIPLA -5% -3.3% 8.7%
DR REDDYS LABORATORIES -5% -7.9% 30.8%
TORRENT PHARMACEUTICALS -2% -5.8% 22.5%
ABBOTT INDIA -2.8% -2.2% 24.5%
ZYDUS LIFESCIENCES -6.4% -6% 60.7%
ALKEM LABORATORIES -2.9% -4.3% 6.8%

FUNDAMENTAL ANALYSIS OF AARTI DRUGS

 
Fundamentals Score
[ Q(TTM): Jun2023, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 AARTIDRUGS is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF AARTI DRUGS

 
Valuation Score
[As on : Sep 25,2023 ]

Ratio Consolidated
P/E
P/B
P/S
28.29
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 179.56 Cr
[Latest Qtr - Jun2023 - Consolidated Results ]

4.26
P/B Calculated based on Book Value of Rs 1,192.44 Cr
[Latest Year - Mar2023 - Consolidated Results ]

1.84
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 2,755.20 Cr
[Latest Qtr - Jun2023 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 15% undervalued companies ! Discover More →

FAIR VALUE OF AARTI DRUGS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
160%
113%
233%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF AARTI DRUGS



AARTI DRUGS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF AARTI DRUGS

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.53
0.38
0.59
0.5
0.52
0.38
0.58
0.49
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF AARTI DRUGS

Pledged Promoter Shares
0 %
As on : Jun2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF AARTI DRUGS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-10.95%
-10.12%
-13.31%
-14.61%
6.29%
25.22%
32.27%
37.92%
QtrlyTrend
0
Latest Qtr: Jun2023
Quarterly Result Analysis →


AARTI DRUGS related INDICES

BSE Indices1W1M1Y
S&P BSE MIDSMALLCAP -1.6% 3.3% 26.5%
S&P BSE 400 MIDSMALLCAP -1.7% 3% 25.6%
S&P BSE 250 SMALLCAP -1.9% 3.5% 28.3%
S&P BSE SMALL CAP -1.9% 2.9% 27.3%
S&P BSE ALLCAP -2.2% 1.9% 13.3%
NSE Indices1W1M1Y
NIFTY MID SMALL400 -1.4% 3.8% 26.9%
NIFTY500 MULTICAP 50:25:25 -2% 2.6% 17.9%
NIFTY SMALLCAP250 -2.1% 4% 28.2%
NIFTY 500 -2.2% 1.9% 12.9%

You may also like the below Video Courses


FAQ about AARTI DRUGS


Is AARTI DRUGS good for long term investment?

As on Sep 25,2023, the Fundamentals of AARTI DRUGS look Strong and hence it may be good for long term investment! See Financial Performance of AARTI DRUGS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is AARTI DRUGS UnderValued or OverValued?

As on Sep 25,2023, AARTI DRUGS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of AARTI DRUGS ?

As on Sep 25,2023, the Intrinsic Value of AARTI DRUGS is Rs. 212.23 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 212.23
Fair Value [Median EV / Sales Model] : Rs. 259.29
Fair Value [Median Price / Sales Model] : Rs. 165.68
Estimated Median Fair Value of AARTI DRUGS : Rs. 212.23

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is AARTI DRUGS trading at a Premium or Discount?

As on Sep 25,2023, AARTI DRUGS is trading at a Premium of 160% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].